Tech Reporter Virgin Islands
SEE OTHER BRANDS

The latest science and technology news from the U.S. Virgin Islands

Tech Reporter Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Virgin Islands.

Press releases published on June 18, 2025

Mavenir unterzeichnet Fremdkapital-Rekapitalisierungstransaktion zur Förderung des weiteren Wachstums

Mavenir unterzeichnet Fremdkapital-Rekapitalisierungstransaktion zur Förderung des weiteren Wachstums

Die Transaktion stärkt die Bilanz von Mavenir und unterstützt den strategischen Fokus auf das profitable Mobile Core Segment Mavenir konzentriert seine Investitionen in Open RAN auf 4G- und 5G-Software und wird seine Investitionen in KI beschleunigen Siris …

Mavenir signe une opération de recapitalisation de sa dette afin de poursuivre sa croissance

Mavenir signe une opération de recapitalisation de sa dette afin de poursuivre sa croissance

Cette opération renforcera le bilan de l’entreprise et soutiendra sa stratégie axée sur son segment Mobile Core rentable Mavenir recentre ses investissements Open RAN sur les logiciels 4G et 5G, ce qui lui permet d’accélérer ses investissements dans l’IA …

Mavenir חותמת על עסקת היוון חובות מחדש כדי להניע צמיחה מתמשכת

Mavenir חותמת על עסקת היוון חובות מחדש כדי להניע צמיחה מתמשכת

עסקה לחיזוק המאזן של Mavenir ולתמוך במיקוד האסטרטגי שלה במגזר הליבה הניידת הרווחי שלה Mavenir תתמקד מחדש בהשקעות ב-Open RAN עבור תוכנות 4G ו-5G, ותאיץ את ההשקעות בבינה מלאכותית Siris תהיה בעלת השליטה בתמיכת מלווים מרכזיים קיימים של Mavenir ריצ'רדסון, טקסס, …

Mavenir Menandatangani Transaksi Rekapitalisasi Utang untuk Mendorong Pertumbuhan yang Berkelanjutan

Mavenir Menandatangani Transaksi Rekapitalisasi Utang untuk Mendorong Pertumbuhan yang Berkelanjutan

Transaksi ini akan memperkuat neraca keuangan Mavenir dan mendukung fokusnya yang strategis pada segmen Mobile Core yang menguntungkan Mavenir akan memfokuskan ulang investasi Open RAN pada perangkat lunak 4G dan 5G, akan mempercepat investasi pada AI …

マベニア (Mavenir)、継続的成長加速に向けた負債再構成取引を締結

マベニア (Mavenir)、継続的成長加速に向けた負債再構成取引を締結

バランスシートの強化と、収益性の高いモバイルコア事業への戦略的集中を支援 Open RAN投資を4Gおよび5Gソフトウェアに再集中、AIへの投資を加速へ 既存の主要貸し手の支援を受け、サイリス (Siris) が支配株主に テキサス州リチャードソン発 , June 19, 2025 (GLOBE NEWSWIRE) -- …

Mavenir, 지속적 성장 위해 부채 재조정에 합의

Mavenir, 지속적 성장 위해 부채 재조정에 합의

Mavenir의 재무 구조 강화 및 수익성 높은 Mobile Core 부문에 전략적 집중 위한 거래 Maveni, 4G와 5G 소프트웨어 중심으로 Open RAN 투자에 재집중하며 AI 투자 가속화할 것 Siris, Mavenir의 기존 핵심 대출 기관들의 지원으로 지배주주 지위 유지할 것 텍사스주 리처드슨, June 19, 2025 (GLOBE NEWSWIRE) -- 클라우드 네이티브 네트워크 인프라 제공업체로 네트워크의 미래를 만들어가고 있는 …

Mavenir Menandatangani Transaksi Permodalan Semula Hutang untuk Memacu Pertumbuhan Berterusan

Mavenir Menandatangani Transaksi Permodalan Semula Hutang untuk Memacu Pertumbuhan Berterusan

Transaksi untuk mengukuhkan kunci kira-kira Mavenir dan menyokong tumpuan strategiknya pada segmen Teras Mudah Alih yang menguntungkan Mavenir akan menumpukan semula pelaburan Open RAN kepada perisian 4G dan 5G serta pelaburan dalam AI Siris akan menjadi …

Mavenir Assina Contrato de Recapitalização de Dívida para Impulsionar Crescimento Contínuo

Mavenir Assina Contrato de Recapitalização de Dívida para Impulsionar Crescimento Contínuo

Transação para fortalecer o balanço da Mavenir e apoiar seu foco estratégico no seu lucrativo segmento Mobile Core A Mavenir vai reorientar os investimentos de Open RAN em software 4G e 5G, acelerando o investimento em IA A Siris será a acionista …

Mavenir ลงนามในธุรกรรมการปรับโครงสร้างหนี้เพื่อขับเคลื่อนการเติบโตอย่างต่อเนื่อง

Mavenir ลงนามในธุรกรรมการปรับโครงสร้างหนี้เพื่อขับเคลื่อนการเติบโตอย่างต่อเนื่อง

ธุรกรรมนี้จะเสริมสร้างฐานะการเงินของ Mavenir และสนับสนุนการมุ่งเน้นกลยุทธ์ในส่วน Mobile Core ที่มีกำไร Mavenir จะปรับการมุ่งเน้นการลงทุน Open RAN ใหม่ที่ซอฟต์แวร์ 4G และ 5G และเร่งการลงทุนใน AI Siris จะเป็นผู้ถือหุ้นใหญ่ด้วยการสนับสนุนจากผู้ให้กู้หลักของ …

Mavenir 签署债务资本重组交易协议,推动持续发展

Mavenir 签署债务资本重组交易协议,推动持续发展

此次交易将可改善 Mavenir 的资产负债表,并为其着重盈利的移动核心业务的战略重点提供支持 Mavenir 将重新聚焦 Open RAN 投资,注重 4G 和 5G 软件,并将加速推进对人工智能的投资 在 Mavenir 现有主要贷方的支持下,Siris 将成为控股股东 理查森,德克萨斯州, June 19, 2025 (GLOBE NEWSWIRE) -- 致力于构建网络未来的云端原生网络基础设施供应商 Mavenir 及其现有投资者 Siris 今天宣布,他们已与 Mavenir …

Mavenir 簽署債務資本重組交易協議,推動持續發展

Mavenir 簽署債務資本重組交易協議,推動持續發展

此次交易將可改善 Mavenir 的資產負債表,並支援其著重盈利的流動核心業務的策略重點 Mavenir 將重新聚焦 Open RAN 投資,注重 4G 和 5G 軟件,並將加速推進對人工智能的投資 在 Mavenir 現有主要貸方機構的支持下,Siris 將成為控股股東 李察遜,德州, June 19, 2025 (GLOBE NEWSWIRE) -- 致力建立網絡未來的雲端原生網絡基礎設施供應商 Mavenir 及其現有投資者 Siris 今天宣布,他們已與 Mavenir …

Launch of the No Limits App: The Platform Designed to Structure and Grow Today’s Entrepreneurs In Switzerland, France, USA

Launch of the No Limits App: The Platform Designed to Structure and Grow Today’s Entrepreneurs In Switzerland, France, USA

Collombey-Muraz, Valais, Switzerland, June 18, 2025 (GLOBE NEWSWIRE) -- After several years of sustained growth, No Limits officially announces the public launch of its all-in-one application across 110 countries. Developed in Switzerland, this platform …

Citibot Awarded Texas Department of Information Resources Contract Through Carahsoft

Citibot Awarded Texas Department of Information Resources Contract Through Carahsoft

CHARLESTON, S.C. and RESTON, Va., June 18, 2025 (GLOBE NEWSWIRE) -- Citibot, a leading provider of interactive chat solutions for Local Governments, and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, today announced that Citibot …

Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide

Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide

Company announcement – No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Body weight reductions of a mean of 11.6% after 28 weeks with dapiglutide escalated up to …

Xtract One Closes $8M Bought Deal Public Offering

Xtract One Closes $8M Bought Deal Public Offering

Over-Allotment Option Exercised in Full THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- …

ThoughtSpot Named a Leader in the 2025 Gartner® Magic Quadrant™ for Analytics and BI Platforms

ThoughtSpot Named a Leader in the 2025 Gartner® Magic Quadrant™ for Analytics and BI Platforms

MOUNTAIN VIEW, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- ThoughtSpot, the Agentic Analytics Platform company, today announced Gartner Inc. has positioned the company in the Leaders quadrant in the 2025 Gartner® Magic Quadrant™ for Analytics and BI …

Sanas and TaskUs Partner to Scale Global Operations with New AI-Powered Noise Cancellation with Omni-directional Capabilities

Sanas and TaskUs Partner to Scale Global Operations with New AI-Powered Noise Cancellation with Omni-directional Capabilities

PALO ALTO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Sanas, provider of the world’s first Real-Time Speech Understanding Platform, today announced that TaskUs, a leading provider of outsourced digital services and next-generation customer experience, has …

Posifa Technologies to Highlight MEMS Anemometer Sensors, A2L Leak Detectors, and Vacuum Gauges and Transducers at Sensors Converge 2025

Posifa Technologies to Highlight MEMS Anemometer Sensors, A2L Leak Detectors, and Vacuum Gauges and Transducers at Sensors Converge 2025

SAN JOSE, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Posifa Technologies today announced that it will exhibit at Sensors Converge 2025, taking place June 25-26 at the Santa Clara Convention Center. In booth 509, the company will spotlight its latest MEMS- …

Bioxytran Secures a Source of GMP Quality Camel Hemoglobin

Bioxytran Secures a Source of GMP Quality Camel Hemoglobin

- First use of camel hemoglobin as a universal oxygen carrier - Unique properties make it an ideal ingredient for oxygen transport BOSTON, MASSACHUSETTS, June 18, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage …

Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway

Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway

- New data show clinical safety and early efficacy of SANA, a first-in-class compound that targets creatine-dependent thermogenesis MONTEVIDEO, Uruguay, June 18, 2025 (GLOBE NEWSWIRE) -- Eolo Pharma, a clinical-stage biotechnology company developing …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service